Prevalence and Characterization of Persistent Dyspnea After Hospitalization
DyHP
1 other identifier
observational
150
1 country
1
Brief Summary
The investigators aim to make an overview of persistent dyspnea at the end of an hospitalization for a respiratory disease using an actual tool, the Multidisciplinary Dyspnea Profile questionnaire.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 21, 2018
CompletedFirst Posted
Study publicly available on registry
January 9, 2019
CompletedStudy Start
First participant enrolled
April 11, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2025
CompletedJuly 23, 2021
July 1, 2021
6.1 years
November 21, 2018
July 22, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Prevalence of persistent dyspnea in the end of an hospitalization for a a respiratory disease
An average of one week, until the end of the hospitalization
Secondary Outcomes (2)
Characterization of persistent dyspnea using MDP
An average of one week, until the end of the hospitalization
Outcome of patients with persistent dyspnea after hospitalization
6 months
Interventions
Multidisciplinary Dyspnea Profile questionnaire at the beginning and the end of an hospitalization
Eligibility Criteria
Every consecutive patient admitted to hospitalization for a respiratory cause having a significant dyspnea
You may qualify if:
- Age over 18 years old
- Able to respond the questionnaire
- Presenting at admission a dyspnea over 3/10 on numerical analogic scale
- Admitted for a respiratory cause
You may not qualify if:
- cognitive impairment
- aphasia
- no french-speaking person
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
ADOREPS
Paris, 75013, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 21, 2018
First Posted
January 9, 2019
Study Start
April 11, 2019
Primary Completion
April 30, 2025
Study Completion
April 30, 2025
Last Updated
July 23, 2021
Record last verified: 2021-07